Application of the dermatology life quality index in clinical trials of biologics for psoriasis. - Wikidata - awgldk - TriplyDB

Application of the dermatology life quality index in clinical trials of biologics for psoriasis.

Application of the dermatology life quality index in clinical trials of biologics for psoriasis.

http://www.wikidata.org/entity/Q37998917

about

A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus Health-related quality of life worsens disproportionately to objective signs of psoriasis after withdrawal of adalimumab therapy.The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.Xinfeng capsule for the treatment of rheumatoid arthritis patients with decreased pulmonary function--a randomized controlled clinical trial.A measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patients.Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis.General measures and quality of life issues in psoriasis.

P2860

Q28082166-380A7E01-51F6-471D-9578-36C369DAB2D6 Q33785083-0ED72C12-D8A4-4D27-8866-222332DA1C08 Q46356347-62D32E13-10E2-40DB-A76F-C685D47E2AAD Q47843244-45BF9457-D882-4B47-B986-0140084CB8D4 Q48081449-1B3303C3-0087-4A25-A304-AEC77CEEA1F4 Q48081870-2AAC6F04-A3C6-4A2A-B0B4-75089CA4D6F2 Q53728309-D6712ABB-9937-4BAE-990C-2F924DDE4268

P2860

Application of the dermatology life quality index in clinical trials of biologics for psoriasis.

http://www.wikidata.org/entity/Q37998917

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Application of the dermatology ...... ls of biologics for psoriasis.

@en

Application of the dermatology ...... ls of biologics for psoriasis.

@nl

type

label

Application of the dermatology ...... ls of biologics for psoriasis.

@en

Application of the dermatology ...... ls of biologics for psoriasis.

@nl

prefLabel

Application of the dermatology ...... ls of biologics for psoriasis.

@en

Application of the dermatology ...... ls of biologics for psoriasis.

@nl

P1433

Q37998917-FFA24E08-351E-4218-B881-115FE3355CBA

P1476

Q37998917-DE6BDE59-6E23-4A39-BDA0-6FAEC0B21F41

P2093

Q37998917-227D18BC-8A68-47BE-A2A4-D1E860CFAA6B

Q37998917-B79D7087-E4DB-44E7-9CE4-15DAC185382F

P2860

Q37998917-0643311B-DE06-4908-B4CB-30B6691186FA

Q37998917-0C4DD484-2B06-40AE-97FC-DF5E94A5E26E

Q37998917-11220A8E-36C6-4613-8076-510DF8C0B7C6

Q37998917-21627416-0300-4959-A866-7D6D5768DBA7

Q37998917-334DC98A-6A72-4642-8BFB-6D214DFB80FB

Q37998917-3819FB5D-D101-43EB-9A6C-D056ECDF017F

Q37998917-3922C955-BA21-4AE1-B9D6-B4526B236019

Q37998917-3B0884E6-5B58-4781-9523-DA7BBBF9971A

Q37998917-3DCBE7BA-EA84-4E1C-8DE5-C64B6F9A7193

Q37998917-4061F036-5EC2-409E-8283-30CB32ABE8AD

P2888

Q37998917-AC5B0511-7F62-44F8-B0F8-3DA99398A29D

P304

Q37998917-48AC82A8-6A1D-4FFD-B943-056C35104FCB

P31

Q37998917-5A1502E4-1480-4CAC-956E-68612C951F21

P356

Q37998917-056A1AF6-E9B0-4562-A059-8FEC6DEDAD42

P433

Q37998917-BF396B55-5B95-413A-961B-C01EF2A921F8

P478

Q37998917-340BF056-0C71-48A4-A776-2F1A70D6225D

P577

Q37998917-E89277B8-EE8E-4072-8895-C89EC632F8CD

P698

Q37998917-E700E1A6-24EE-425F-8AE7-90A9A9953083

P356

S11655-012-1007-0

P1433

Chinese Journal of Integrated Medicine

P1476

Application of the dermatology ...... ls of biologics for psoriasis.

@en

P2093

Mohammad Khurshid Azam Basra

http://www.w3.org/2001/XMLSchema#string

Sadath Hussain

http://www.w3.org/2001/XMLSchema#string

P2860

Psoriasis: epidemiology, clinical features, and quality of life

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Connections between psoriasis and Crohn's disease.

What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature.

The impact of psoriasis on quality of life.

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

P2888

s11655-012-1007-0

P304

179-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11655-012-1007-0

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22466941

http://www.w3.org/2001/XMLSchema#string